R&D News | pharmaphorum

News

Fifth scientist convicted in GSK trade secrets case

A scientist working in Switzerland has become the fifth person to be convicted of attempting to steal trade secrets from pharmaceutical group GlaxoSmithKline in a case that stretched back s

News

AstraZeneca plans new US R&D hub as revenues rocket

AstraZeneca has revealed plans to set up a new strategic R&D hub in Cambridge, Massachusetts as it reported a massive increase in first-quarter revenues, driven by COVID-19 and oncology

News

Novo Nordisk once-weekly insulin clears first phase 3 test

For many patients with type 2 diabetes, having to inject basal insulin every day is a burdensome fact of life, but Novo Nordisk is trying to change that.

News

Lilly fires a broadside at Novo Nordisk's obesity ambitions

Denmark's Novo Nordisk has been almost single-handedly rebuilding the market for drugs to treat obesity over the last few years with its GLP-1 agonist drugs

News

Google, Sanofi back UK biotech OMass' $100m second round

OMass Therapeutics has raised an impressive $100 million in a Series B financing that is said to be the largest ever for a UK biotech focusing on small-molecule drug development.

News

Parasitic biting insect on background of epidermis detail. Disgusting carrier of encephalitis, Lyme disease or babesiosis infections. Tick-borne diseases

Readout sets up phase 3 for Valneva/Pfizer's Lyme disease ja...

There's only one vaccine candidate for tick-borne infection Lyme disease in clinical development – Valneva and Pfizer's VLA15 – and it has just moved another step closer to being available.

Fifth scientist convicted in GSK trade secrets case

AstraZeneca plans new US R&D hub as revenues rocket

Novo Nordisk once-weekly insulin clears first phase 3 test

Lilly fires a broadside at Novo Nordisk's obesity ambitions

Google, Sanofi back UK biotech OMass' $100m second round

Readout sets up phase 3 for Valneva/Pfizer's Lyme disease ja...

Five indications added to Pharmacy First prescribing scheme

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks